Davood Tofighi

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Nanomedicine (London, England)

Multivariate behavioral research

Psychological methods

University of New Mexico

Arizona State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of New Mexico Sep 01 2016

United States

Assistant Professor :: Psychology

Georgia Institute of Technology Jan 07 2011 - Aug 30 2016

United States

Assistant Professor :: school of psychology

Education History

Arizona State University Aug 15 2005 - Dec 01 2010

United States

PHD :: psychology

Publications

Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Yu-Yu Hsiao, Eric S Kruger, M Lee Van Horn, Davood Tofighi, David P MacKinnon, Katie A Witkiewitz
Latent Class Mediation: A Comparison of Six Approaches. Multivariate behavioral research 56 (4) (2020)
Davood Tofighi, Ken Kelley
Improved inference in mediation analysis: Introducing the model-based constrained optimization procedure. Psychological methods 25 (4) (2020)
Davood Tofighi, Ken Kelley
Indirect Effects in Sequential Mediation Models: Evaluating Methods for Hypothesis Testing and Confidence Interval Formation. Multivariate behavioral research 55 (2) (2019)

Davood Tofighi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Davood Tofighi